Alopecia Areata: How Clinical Research is Growing Hope

Alopecia Areata is an autoimmune disease that causes unpredictable hair loss and greatly affects quality of life, but advances in clinical research are offering new hope. With recent approvals of JAK inhibitors and ongoing trials exploring novel therapies, treatment options are expanding, though unmet needs remain for children, severe cases, and those with comorbidities. This whitepaper examines the evolving science, clinical trial challenges, and the role of real-world evidence and emerging technologies in shaping more effective therapies

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

2026 AACR Annual Meeting

17th April 2026 to 22nd April 2026
San Diego Convention Center

Life Science Innovation Northwest 2026

21st April 2026 to 22nd April 2026
Seattle Convention Center

02/17/2026

Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development

RALEIGH, N.C.; February 17, 2026 – Caidya, a leading global,...
Skip to toolbar